157 related articles for article (PubMed ID: 6099709)
1. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
Prusoff WH; Mancini WR; Lin TS; Lee JJ; Siegel SA; Otto MJ
Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside analogues as antiviral agents.
de Clercq E
Acta Microbiol Acad Sci Hung; 1981; 28(3):289-306. PubMed ID: 6272552
[No Abstract] [Full Text] [Related]
3. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
[TBL] [Abstract][Full Text] [Related]
4. The incorporation of 5-iodo-5'-amino-2',5-dideoxyuridine and 5-iodo-2'-deoxyuridine into herpes simplex virus DNA. Relationship between antiviral activity and effects on DNA structure.
Fischer PH; Chen MS; Prusoff WH
Biochim Biophys Acta; 1980 Feb; 606(2):236-45. PubMed ID: 6243982
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5'-amino-5-iodo-2',5'-dideoxyuridine and 2-deoxy-D-glucose on latent ganglionic herpes simplex virus infection.
Pavan-Langston D; Park NH; De Clercq E
Antiviral Res; 1984 Apr; 4(1-2):53-61. PubMed ID: 6331305
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
Field H; McMillan A; Darby G
J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Larsson A; Oberg B
Antimicrob Agents Chemother; 1981 May; 19(5):927-9. PubMed ID: 6271053
[TBL] [Abstract][Full Text] [Related]
8. In vitro sensitivity of macropodid herpesvirus 2 to selected anti-herpetic compounds.
Smith G
J Wildl Dis; 1996 Jan; 32(1):117-20. PubMed ID: 8627922
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Coen DM; Fleming HE; Leslie LK; Retondo MJ
J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of 5'-amino-5'-deoxythymidine and 5-iodo-2'-deoxyuridine against Herpes Simplex virus infections in vitro.
Fischer PH; Lee JJ; Chen MS; Lin TS; Prusoff WH
Biochem Pharmacol; 1979 Dec; 28(23):3483-6. PubMed ID: 231443
[No Abstract] [Full Text] [Related]
12. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
Suzutani T; Machida H; Sakuma T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1046-52. PubMed ID: 2847637
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the antiviral activity of 5'-amino-5'-deoxythymidine and its incorporation into herpes simplex virus type 1 DNA.
Otto MJ; Prusoff WH
Antiviral Res; 1984 Oct; 4(5):271-80. PubMed ID: 6097180
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus: inhibition of replication by three new drugs.
Lin JC; Smith MC; Cheng YC; Pagano JS
Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771
[TBL] [Abstract][Full Text] [Related]
15. Specific herpes simplex virus-induced incorporation of 5-iodo-5'-amino-2',5'-dideoxyuridine into deoxyribonucleic acid.
Chen MS; Ward DC; Prusoff WH
J Biol Chem; 1976 Aug; 251(16):4833-8. PubMed ID: 182681
[TBL] [Abstract][Full Text] [Related]
16. Interactions between virus and antiviral compounds in the host cell.
Harmenberg J
Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
[No Abstract] [Full Text] [Related]
17. Kinetics of the interaction of monophosphates of the antiviral nucleosides 2'-fluoro-1-beta-D-arabinofuranosylpyrimidine and (E)-5-(2-bromovinyl)-2'-deoxyuridine with thymidylate kinases from Vero cells and herpes simplex virus types 1 and 2.
Chen MS; Amico LA; Speelman DJ
Antimicrob Agents Chemother; 1984 Nov; 26(5):778-80. PubMed ID: 6083755
[TBL] [Abstract][Full Text] [Related]
18. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
[TBL] [Abstract][Full Text] [Related]
19. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
[No Abstract] [Full Text] [Related]
20. Antiviral activity of 5-iodo-2'-deoxyuridine and related drugs in human keratinocytes infected in vitro with herpes simplex virus type 1.
Reuveni H; Bull CO; Landry ML; Milstone LM; Schwartz PM
Skin Pharmacol; 1991; 4(4):291-7. PubMed ID: 1665069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
